Identification of prognostic biomarkers for prostate cancer.
about
A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancerCandidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and bloodGene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy.Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.Identification of genes associated with local aggressiveness and metastatic behavior in soft tissue tumors.Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.Clonality characterization of natural epitope-specific antibodies against the tumor-related antigen topoisomerase IIa by peptide chip and proteome analysis: a pilot study with colorectal carcinoma patient samples.Patterns of expression of DNA repair genes and relapse from melanoma.Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.Prognostic value of discs large homolog 7 transcript levels in prostate cancer.Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients.Peptide receptor targeting in cancer: the somatostatin paradigm.TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma.Novel Nine-Exon AR Transcripts (Exon 1/Exon 1b/Exons 2-8) in Normal and Cancerous Breast and Prostate Cells.Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors.Clinically relevant genetic characterization of prostate tumors: how close are we to the goal?High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer.Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1.Gene panel model predictive of outcome in patients with prostate cancer.Hypoxia on the Expression of Hepatoma Upregulated Protein in Prostate Cancer Cells.Identification of markers of prostate cancer progression using candidate gene expression.DNA repair and replication proteins as prognostic markers in melanoma.Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New NomenclaturePET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors
P2860
Q28478225-2B2F2184-6478-48E1-BCD0-F4DA11035959Q31045532-4CDEA7E8-23AD-438C-9584-8D732247F496Q33361134-407E00A4-6B24-454E-B193-77FAE5FB94FFQ33507490-1E02D14E-5623-4FA8-B298-09A08B2CCE85Q33655346-F8AA8B99-45C4-48CC-99A2-2F02948038C4Q33714055-DDE26152-B93A-4947-B4EC-852BB43D09D2Q34164365-C56C5C59-77F2-4625-9063-2919128A3B74Q34273603-9C5940D3-74A1-4B4A-BA3D-0CCC104636E8Q34962331-00E5EFD9-61EA-4D6D-9CF8-543C3DE9BF42Q35070576-E19FEEFC-E68B-407E-88BE-BCC6337BFB9CQ36043833-F762D6F3-78F1-4BED-8D57-A1ECF6A778A5Q36638046-C2E8F002-DA47-4299-B5E4-3D2A70D0950BQ37188707-F40B9818-BF78-4513-8FD3-F4F3A8544905Q37631437-5C352542-3007-4F35-9647-83576AE67C34Q37898112-9A578A29-4440-4A85-A72A-20D3A1C0AFF9Q38356863-9B81E773-6032-4DDD-8A73-96BCC4B04D14Q38873431-57EE7C88-6EB9-455F-A5BC-9110115BE82EQ39393568-F8801069-8586-4867-8E33-2DA1E81AADAAQ39403730-DD24CF87-8D3E-4651-B7DC-973DED0809E4Q39631128-7AEB21A2-78D7-4F0D-905A-B114DC73F9E1Q40177572-1A698C68-EF5D-4BBE-B379-DEF1C2F3DD09Q45102162-E9AA3690-EAEE-4A9B-8FB4-28CCC1A2F832Q47805050-975C7414-1B65-4C03-8E06-2724106E3BC5Q57144951-BA6FA437-011E-48E4-84D7-02C2680431B8Q59074896-D76512FF-C3FA-4ECC-A31E-904EE6982862
P2860
Identification of prognostic biomarkers for prostate cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Identification of prognostic biomarkers for prostate cancer.
@ast
Identification of prognostic biomarkers for prostate cancer.
@en
Identification of prognostic biomarkers for prostate cancer.
@nl
type
label
Identification of prognostic biomarkers for prostate cancer.
@ast
Identification of prognostic biomarkers for prostate cancer.
@en
Identification of prognostic biomarkers for prostate cancer.
@nl
prefLabel
Identification of prognostic biomarkers for prostate cancer.
@ast
Identification of prognostic biomarkers for prostate cancer.
@en
Identification of prognostic biomarkers for prostate cancer.
@nl
P2093
P1476
Identification of prognostic biomarkers for prostate cancer.
@en
P2093
C Dilara Savci-Heijink
Craig Spiro
Dagmar Marie Kube
Eric W Klee
Farhad Kosari
George Vasmatzis
Jan Marie A Munz
Jeff Slezak
John C Cheville
Lori Tillmans
P304
P356
10.1158/1078-0432.CCR-07-1494
P407
P577
2008-03-01T00:00:00Z